Caffeine and Parkinson's disease: Are we getting our fix on risk-modifying gene-environment interactions?

European Journal of Neurology

Volumn 18, Issue 5, 2011, Pages 671-672

  Mellick, G D ^a   Ross, O A ^b  

^a GRIFFITH UNIVERSITY   (Australia)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR A2A; CAFFEINE; CYTOCHROME P450 1A2; CYTOCHROME P450 2D6; LEUCINE RICH REPEAT KINASE 2; PARKIN; UNCLASSIFIED DRUG;

CIGARETTE SMOKING; DISEASE COURSE; EDITORIAL; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; PARKINSON DISEASE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RISK REDUCTION;

CAFFEINE; CYTOCHROME P-450 CYP1A2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE; RECEPTOR, ADENOSINE A2A;

EID: 79954804537     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03350.x     Document Type: Editorial

References (7)

1. Chen H, Huang X, Guo X, et al. Smoking duration, intensity, and risk of Parkinson disease. Neurology 2010; 74: 878-884.
2. Elbaz A, Clavel J, Rathouz PJ, et al. Professional exposure to pesticides and Parkinson disease. Ann Neurol 2009; 66: 494-504.
3. Ross OA, Farrer MJ. Parkinson disease: Parkinson disease-moving beyond association. Nat Rev Neurol. 2010; 6: 305-307.
4. Mellick GD. CYP450, genetics and Parkinson's disease: gene x environment interactions hold the key. J Neural Transm Suppl 2006; 70: 159-165.
5. Popat R, Van Den eeden S, Tanner CM, et al. Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease. Eur J Neurol 2011; 18: 756-765.
6. Tan EK, Peng R, Teo YY, et al. Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study. Hum Mutat 2010; 31: 561-568.
7. Evans AH, Lawrence AD, Potts J, et al. Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 317-321.